Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study
Main Authors: | Claudia A. Chiriboga, Claudio Bruno, Tina Duong, Dirk Fischer, Eugenio Mercuri, Janbernd Kirschner, Anna Kostera-Pruszczyk, Birgit Jaber, Ksenija Gorni, Heidemarie Kletzl, Imogen Carruthers, Carmen Martin, Francis Warren, Renata S. Scalco, Kathryn R. Wagner, Francesco Muntoni, the JEWELFISH Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-07-01
|
Series: | Neurology and Therapy |
Online Access: | https://doi.org/10.1007/s40120-023-00503-7 |
Similar Items
-
Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study
by: Claudia A. Chiriboga, et al.
Published: (2023-02-01) -
Health economic evaluation of risdiplam in patients with spinal muscular atrophy
by: А. S. Kolbin, et al.
Published: (2021-10-01) -
Spinal muscular atrophy type 2: efficacy of risdiplam in a 7-year-old child
by: T. A. Kryuchkova, et al.
Published: (2022-08-01) -
Oral risdiplam for specific therapy in adult patients with 5q spinal muscular atrophy in the Moscow region
by: Ekaterina S. Novikova
Published: (2023-09-01) -
Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany
by: Andreas Hahn, et al.
Published: (2022-10-01)